Showing results (1091-1100 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|November 6, 2007
Genetic variability in CYP2A6 and the pharmacokinetics of nicotineJill C Mwenifumbo, Rachel F TyndalePharmacogenomics|November 6, 2007
Clinical pharmacogenetics in pediatric patientsAnwar Husain, Jennifer A Loehle, David W HeinPharmacogenomics|November 6, 2007
Routine pharmacogenetic testing in clinical practice: dream or reality?Iris GrossmanPharmacogenomics|February 28, 2007
Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapyXue Zhang, Robert B DiasioPharmacogenomics|February 9, 2007
Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patientsR J H M van der Straaten, Judith A M Wessels, Jeska K de Vries-Bouwstra, et al.Pharmacogenomics|December 26, 2006
Graying anatomy? Toward molecular tumor characterizationHoward McLeodPharmacogenomics|December 23, 2006
DOPA decarboxylase gene is associated with nicotine dependenceHeping Zhang, Yuanqing Ye, Xueqing Wang, et al.Pharmacogenomics|December 23, 2006
Gene-expression signatures in oncology diagnosticsAbhijit Mazumder, Yixin WangPharmacogenomics|December 23, 2006
Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technologyAmit K Mitra, Devendra K AgrawalPharmacogenomics|December 23, 2006
Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness?Vural Ozdemir, Arzu Gunes, Marja-Liisa Dahl, et al.Pageof 276